Media Coverage
The latest coverage of StrideBio.
Gene therapy startup StrideBio signs collaboration deal with Duke University
$81M raise for gene therapy firm in RTP will help double headcount, CEO says
Gene therapy startup StrideBio lands $81.5M in capital, new investors
StrideBio Closes $81.5M Series B Financing
Takeda, Sarepta double down on a biotech partner’s platform to engineer better AAV capsids by mapping out their structure
StrideBio, Sarepta Partner to Advance Gene Therapies for Dravet, Other Rare Diseases
Sarepta and StrideBio Partner to Advance Gene Therapies for Rett Syndrome, Other Disorders
Sarepta Therapeutics, StrideBio Team Up to Develop Gene Therapy for Angelman Syndrome, Other Diseases
Sarepta picks up a slate of preclinical gene therapy programs, seeding new StrideBio deal with $48M upfront
RTP gene tech firm lands deal worth up to $90M for 8 nervous system therapies
StrideBio, Takeda Pair to Develop New Gene Therapies for Friedreich’s Ataxia
Durham life science startup StrideBio names CEO
Durham life science startup StrideBio raises $15.7M in oversubscribed VC round
StrideBio Closes $15.7M in Series A Financing
StrideBio closes financing round with $15.7M
On heels of license deal, StrideBio secures seed funding from Hatteras Venture Partners
With new deal, company spun out of UNC moving forward in gene therapy